In Friday’s Wall Street session, Bausch Health Companies Inc (NYSE:BHC) shares traded at $5.98, up 8.53% from the previous session.
BHC stock price is now 22.53% away from the 50-day moving average and -13.45% away from the 200-day moving average. The market capitalization of the company currently stands at $2.21B.
With the price target reduced from $9 to $3, Piper Sandler Downgraded its rating from Neutral to Underweight for Bausch Health Companies Inc (NYSE: BHC). On July 10, 2024, Raymond James recently initiated its ‘Mkt Perform’ rating on the stock quoting a target price of $8, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Paulson John, Director bought 1,005,376 shares of the company’s stock on Jun 12 ’25. The stock was bought for $5,499,407 at an average price of $5.47. Upon completion of the transaction, the Director now directly owns 29,227,643 shares in the company, valued at $174.78 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 11 ’25, Director Paulson John bought 1,029,098 shares of the business’s stock. A total of $5,392,474 was incurred on buying the stock at an average price of $5.24. This leaves the insider owning 28,222,267 shares of the company worth $168.77 million. A total of 21.23% of the company’s stock is owned by insiders.
During the past 12 months, Bausch Health Companies Inc has had a low of $3.96 and a high of $9.85. The fifty day moving average price for BHC is $4.8804 and a two-hundred day moving average price translates $6.90955 for the stock.
The latest earnings results from Bausch Health Companies Inc (NYSE: BHC) was released for 2025-03-31. The company reported revenue of $2.26 billion for the quarter, compared to $2.15 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.92 percent.
